Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Howarth

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 15, 2025
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysisDanilo Di Bona, Giovanni Paoletti, Palma Carlucci, et al.
Therapeutic Advances in Respiratory Disease|August 16, 2022
Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studiesThomas B Casale, Autumn Burnette, Arnaud Bourdin, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 13, 2022
Validation and further insight into the International Severe Asthma Registry (ISAR) eosinophil gradient algorithm in the Wessex AsThma CoHort of difficult asthma (WATCH) using historical blood eosinophil counts and induced sputumClair Barber, Adnan Azim, Colin Newell, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 2, 2023
Real-world characterisation of patients with chronic rhinosinusitis with nasal polyps with and without surgery in EnglandVictoria S Benson, Qinggong Fu, Shibing Yang, et al.
Modern Rheumatology|November 7, 2024
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: Long-term observation of the MARS studyTomonori Ishii, Hideaki Kunishige, Tamami Kobayashi, et al.
The Journal of Allergy and Clinical Immunology|July 26, 2012
Tissue factor-bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivoJin-Ah Park, Asma S Sharif, Daniel J Tschumperlin, et al.
Frontiers in Allergy|March 23, 2026
Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysisEnrico Heffler, Diana Jarreta, Chang-Qing Zhu, et al.
Clinical and Translational Allergy|October 25, 2021
Prospective Italian real-world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reportsLaura Pini, Cristiano Caruso, Stefania Colantuono, et al.
Respiratory Research|March 5, 2022
Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthmaStephanie Korn, Peter Howarth, Steven G Smith, et al.
Modern Rheumatology|December 15, 2023
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: A 48-week interim analysis of the MARS studyTomonori Ishii, Hideaki Kunishige, Tamami Kobayashi, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 15, 2025
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysisDanilo Di Bona, Giovanni Paoletti, Palma Carlucci, et al.
Therapeutic Advances in Respiratory Disease|August 16, 2022
Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studiesThomas B Casale, Autumn Burnette, Arnaud Bourdin, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 13, 2022
Validation and further insight into the International Severe Asthma Registry (ISAR) eosinophil gradient algorithm in the Wessex AsThma CoHort of difficult asthma (WATCH) using historical blood eosinophil counts and induced sputumClair Barber, Adnan Azim, Colin Newell, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 2, 2023
Real-world characterisation of patients with chronic rhinosinusitis with nasal polyps with and without surgery in EnglandVictoria S Benson, Qinggong Fu, Shibing Yang, et al.
Modern Rheumatology|November 7, 2024
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: Long-term observation of the MARS studyTomonori Ishii, Hideaki Kunishige, Tamami Kobayashi, et al.
The Journal of Allergy and Clinical Immunology|July 26, 2012
Tissue factor-bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivoJin-Ah Park, Asma S Sharif, Daniel J Tschumperlin, et al.
Frontiers in Allergy|March 23, 2026
Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysisEnrico Heffler, Diana Jarreta, Chang-Qing Zhu, et al.
Clinical and Translational Allergy|October 25, 2021
Prospective Italian real-world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reportsLaura Pini, Cristiano Caruso, Stefania Colantuono, et al.
Respiratory Research|March 5, 2022
Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthmaStephanie Korn, Peter Howarth, Steven G Smith, et al.
Modern Rheumatology|December 15, 2023
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: A 48-week interim analysis of the MARS studyTomonori Ishii, Hideaki Kunishige, Tamami Kobayashi, et al.
Pageof 11